Abstract: The system enables a subject himself to decide on a proper remedial measure, without obtaining particular instruction directly from a medical professional, by providing an advice corresponding to a decision criteria of a plurality of classifications (3x4=12) stored in the storage unit, based on a plurality of autonomic nerve function age ranks and a plurality of autonomic nerve function age ranks A screening system for fatigue and stress has a storage unit which, during screening for fatigue and stress, stores master data composed of reference values for each age, a decision unit which decides by comparing a measurement data obtained by electrocardiogram and pulse wave measurement of the subject with the reference value, and outputs a result of decision classified into the plurality of classifications, and a computing unit which receives the decision results, and calculates autonomic nerve function age ranks, wherein the decision means has an autonomic nerve decision unit which decides autonomic nerve strengt

Abstract: It is known that L-menthol controls smooth muscle contraction. In order to use L-menthol in practice as a digestive tract contraction inhibiting agent in digestive tract endoscopy, it is required to devise means of giving a formulation in which an L-menthol-containing formulation remains stable and transparent or little cloudy over a long time after the production and which shows little foaming at the administration. In the present invention, an antifoaming agent is further added to a formulation for inhibiting smooth muscle contraction or a peristaltic contraction in a digestive tract containing a L-menthol emulsion having an average particle size of less than 100 nm. Thus, it is possible to obtain a formulation that remains stable over a long time, has a high light transmittance, and produces little foam when filled into a container and sprayed at a target area to inhibit contraction to facilitate observation of the area in endoscopic examination of the digestive tract etc.

Abstract: It is known that L-menthol controls smooth muscle contraction. In order to use L-menthol in practice as a digestive tract contraction inhibiting agent in digestive tract endoscopy, it is required to devise means of giving a formulation in which an L-menthol-containing formulation remains stable and transparent or little cloudy over a long time after the production and which shows little foaming at the administration. In the present invention, an antifoaming agent is further added to a formulation for inhibiting smooth muscle contraction or a peristaltic contraction in a digestive tract containing a L-menthol emulsion having an average particle size of less than 100 nm. Thus, it is possible to obtain a formulation that remains stable over a long time, has a high light transmittance, and produces little foam when filled into a container and sprayed at a target area to inhibit contraction to facilitate observation of the area in endoscopic examination of the digestive tract etc.

Abstract: It is known that L-menthol controls smooth muscle contraction. In order to use L-menthol in practice as a digestive tract contraction inhibiting agent in digestive tract endoscopy, it is required to devise means of giving a formulation in which an L-menthol-containing formulation remains stable and transparent or little cloudy over a long time after the production and which shows little foaming at the administration. In the present invention, an antifoaming agent is further added to a formulation for inhibiting smooth muscle contraction or a peristaltic contraction in a digestive tract containing a L-menthol emulsion having an average particle size of less than 100 nm. Thus, it is possible to obtain a formulation that remains stable over a long time, has a high light transmittance, and produces little foam when filled into a container and sprayed at a target area to inhibit contraction to facilitate observation of the area in endoscopic examination of the digestive tract etc.

Abstract: The present invention provides a neurodegenerative disease therapeutic agent containing as its active ingredient a (15R)-isocarbacycline derivative indicated by the following formula [I] or a 15-deoxy-isocarbacycline derivative indicated by the following formula [III]: (wherein, R1 represents a C1-C6 alkylene group, and R2 represents a hydrogen atom, a C1-C7, alkyl group or protective group); or, (wherein, R1 and R2 are the same as those defined in formula [I]).

Abstract: A boiler is provided with a radiation heat transfer section in its combustion chamber, which has therein, at least one regenerative-heating burner system including a pair of burners each with a regenerative bed. The burners receive combustion air and exhaust combustion gas which passes through the regenerative beds. Combustion is alternately effected in one of the burners and combustion gas is passed into the other burner, and exhausted through the corresponding regenerative bed of this other burner. Surplus thermal energy which is not completely consumed in the radiation heat transfer section is recovered in the regenerative bed. Combustion air than passes through the heated regenerative bed to heat the air. The boiler temperature is kept flat across the boiler. That is, the temperature is kept almost constant across the combustion chamber. This is done by maintaining a high rate of forced supply of more than 60 m/s for the combustion air.

Abstract: A boiler is provided with a radiation heat transfer section in its combustion chamber, which has therein, at least one regenerative-heating burner system including a pair of burners each with a regenerative bed. The burners receive combustion air and exhaust combustion gas which passes through the regenerative beds. Combustion is alternately effected in one of the burners and combustion gas is passed into the other burner, and exhausted through the corresponding regenerative bed of this other burner. Surplus thermal energy which is not completely consumed in the radiation heat transfer section is recovered in the regenerative bed. Combustion air then passes through the heated regenerative bed to heat the air. The boiler temperature is kept flat across the boiler. That is, the temperature is kept almost constant across the combustion chamber. This is done by maintaining a high rate of forced supply of more than 60 m/s for the combustion air.

Abstract: A boiler has a radiation heat transfer section with opposite sides and boiler water tubes therein for passing boiler water to be heated by combustion gas in the radiation heat transfer section. The boiler water moves substantially in a selected direction in the radiation heat transfer section. A plurality of regenerative-heating-type burner systems are connected to the radiation heat transfer section. Each burner system has a regenerative bed and a burner. The burner systems are in pairs on the opposite sides of the radiation heat transfer section. A first mechanism supplies combustion air through the bed and to the burner of each burner system while a second mechanism supplies fuel to each burner system to form a flame that produces the combustion gas. A third mechanism causes the flow of air and gas to be changed over at intervals. Each pair of burner systems is controlled separately for defining a plurality of temperature zones in the radiation heat transfer section.